Fund image

Ysios Capital

Ysios Capital

Ysios Capital is a leading life sciences investor financing highly innovative companies worldwide.

  • Use: Go2Market;
  • Date closing: -
  • Amount: -
  • Industry focus: Health;
  • Total budget: 216M €
  • Entity type: Venture Capital
  • Vertical focus: biotechnology, emerging pharmaceuticals, healthcare and medical technology
  • Website: http://www.ysioscapital.com/
  • Status:
    Open
  • Funding type: Equity investment;
  • Geographic focus: Europe;
  • Public/Private: Private
  • Stage focus: Seed; Series A; Series B;
  • Applicant target: Startup;

Overview

Ysios Capital provides biotech ventures with the resources to develop novel therapies for indications with high unmet medical needs.

They invest in companies that will have a positive impact on patients and society and in companies bringing life-changing treatments to patients, with a focus on indications with high unmet need.

Ysios Capital has raised a total of €411.4M across 3 funds, their latest being Ysios BioFund III. This fund was announced on Jun 10, 2020 and raised a total of €216M.

 

Portfolio: Adcendo, Aelix, Amgen, Galecto.

Last updated on 2023-05-04 11:52

Ysios Capital FAQ

0 questions

Featured Funds

Fund image

Mucker Capital

  • Usage: Go2Market; Scale-up;
  • Entity type: Venture Capital
  • Funding type: Equity investment;
  • Status: Open
  • Geographic focus: Canada; United States of America;
  • 0 reviews 0 questions
Fund image

ICO - Instituto Crédito Oficial

  • Usage: R&D; Go2Market; Social & Environment; Other;
  • Entity type: Public Agency
  • Total: 8B €
  • Funding type: Equity investment;
  • Status: Open
  • Geographic focus: Spain;
  • 0 reviews 1 questions
  • Usage: R&D;
  • Entity type: Public Agency
  • Total: 30M £
  • Funding type: Grant;
  • Status: Open
  • Geographic focus: United Kingdom;
  • 0 reviews 45 questions